Malaysia is embarking on a clinical study to evaluate the drug Tocilizumab for the treatment of severe cases of Covid-19.
Led by Universiti Malaya Faculty of Medicine dean Professor Datuk Dr Adeeba Kamarulzaman, the trial is underway at Universiti Malaya Medical Centre (UMMC), together with three public hospitals: Sungai Buloh Hospital, Kuala Lumpur Hospital and Tuanku Jaafar Hospital, Seremban.
We are proud to announce a remarkable milestone for Universiti Malaya Medical Centre (UMMC) in the ZENITH High Proteinuria (D4325C00010) study. Under the leadership of
We are thrilled to announce that Universiti Malaya Medical Centre (UMMC), under the leadership of Assoc. Prof. Dr. Rozita Binti Abdul Malik, has been recognized
This morning, the Clinical Investigation Centre (CIC) at Universiti Malaya Medical Centre (UMMC) hosted the MSD and UMMC Clinical Trial Partnership Meeting, a significant step
We are proud to celebrate the exceptional achievements of Assoc. Prof. Dr. Adlinda Alip and her dedicated team at Universiti Malaya Medical Centre (UMMC) in
© CIC. All Rights Reserved. 2024